C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/24 (2006.01) A61K 39/395 (2006.01) A61P 15/00 (2006.01) C07K 16/18 (2006.01) G01N 33/543 (2006.01) G01N 33/68 (2006.01) G01N 33/58 (2006.01)
Patent
CA 2532535
The content of a histamine-releasing factor (HRF) protein in a biological sample of a subject is measured and the HRF protein content is compared with that of a normal biological sample. An HRF protein content considerably higher than that of the normal biological sample is employed as an indication of a disease relating to endometriosis or a risk thereof.
La teneur en protéine de facteur histaminolibérateur (HRF) dans un échantillon biologique d'un sujet est mesuré et elle est comparée à celle d'un échantillon biologique normal. Une teneur en protéine HRF considérablement supérieure à celle de l'échantillon biologique normal est utilisée comme une indication d'une maladie associée à une endométriose ou d'un risque de telle maladie.
Kosugi Yoshinori
Kuroda Masahiko
Ohbayashi Tetsua
Oikawa Kosuke
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Periodock Co. Ltd.
LandOfFree
Method of diagnosing disease relating to endometriosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing disease relating to endometriosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing disease relating to endometriosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1728244